Inventor · disambiguated record
Mark J. Tebbe
Also filed as: TEBBE MARK J · TEBBE MARK JOSEPH
22 granted patents·7 pending applications·324 citations·filing 1995–2021
95Inventor score
Files withFORMA THERAPEUTICS INC13LILLY CO ELI8BABINE ROBERT EDWARD3VERTEX PHARMA2ARKUDA THERAPEUTICS1
Top patents by PatentIndex Score
29 records- 0197US9422281B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2014·Granted Aug 23, 2016·25 cites·35 claims
- 0296US10377769B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·10 cites·28 claims
- 0396US5891874AAnti-viral compoundLILLY CO ELI·Filed 1997·Granted Apr 6, 1999·163 cites·12 claims
- 0494US10472342B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Nov 12, 2019·4 cites·25 claims
- 0593US7820671B2Peptidomimetic protease inhibitorsVERTEX PHARMA·Filed 2001·Granted Oct 26, 2010·33 cites·8 claims
- 0692US8252923B2Peptidomimetic protease inhibitorsBABINE ROBERT EDWARD·Filed 2008·Granted Aug 28, 2012·14 cites·19 claims
- 0790US10457655B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2017·Granted Oct 29, 2019·3 cites·46 claims
- 0890US10399951B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·5 cites·27 claims
- 0987US10703764B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Jul 7, 2020·2 cites·19 claims
- 1087US10450286B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Oct 22, 2019·3 cites·27 claims
- 1186US10995078B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2020·Granted May 4, 2021·1 cites·2 claims
- 1284US8529882B2Peptidomimetic protease inhibitorsBABINE ROBERT EDWARD·Filed 2012·Granted Sep 10, 2013·3 cites·5 claims
- 1379US10800750B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Oct 13, 2020·0 cites·20 claims
- 1476US2021214323A1Novel compounds and compositions for inhibition of fasnFORMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1574US11084831B1Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2020·Granted Aug 10, 2021·0 cites·14 claims
- 1669US7576108B2Substituted arylcyclopropylacetamides as glucokinase activatorsLILLY CO ELI·Filed 2003·Granted Aug 18, 2009·7 cites·18 claims
- 1769US7405305B2Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitorsLILLY CO ELI·Filed 2003·Granted Jul 29, 2008·6 cites·9 claims
- 1866US5821242AAnti-viral compoundsLILLY CO ELI·Filed 1997·Granted Oct 13, 1998·12 cites·14 claims
- 1965US2014294763A1Peptidomimetic protease inhibitorsVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2065US2016257699A1Benzopiperazine compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2161US5545653AAnti-viral compoundsLILLY CO ELI·Filed 1995·Granted Aug 13, 1996·18 cites·19 claims
- 2257US6114327AAnti-viral compoundsLILLY CO ELI·Filed 1999·Granted Sep 5, 2000·9 cites·20 claims
- 2357US2012064034A1Peptidomimetic protease inhibitorsBABINE ROBERT EDWARD·Filed 2011·Application pending·0 cites
- 2444US5693661AAnti-viral compoundsLILLY CO ELI·Filed 1995·Granted Dec 2, 1997·6 cites·31 claims
- 2543US7396846B2Growth hormone secretagoguesLILLY CO ELI·Filed 2003·Granted Jul 8, 2008·0 cites·22 claims
- 2643US2016256458A1Benzopiperazine compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2743US2021163471A1Progranulin modulators and methods of using the sameARKUDA THERAPEUTICS·Filed 2018·Application pending·0 cites
- 2831US2006167268A1Growth hormone secretagoguesELI LILLY AND COMPANY PATENT D·Filed 2003·Application pending·0 cites
- 2929US9963462B2Sepiapterin reductase inhibitorsQUARTET MEDICINE INC·Filed 2016·Granted May 8, 2018·0 cites·27 claims
Join the waitlist — get patent alerts
Get an alert when Mark J. Tebbe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →